HEADER LIPID BINDING PROTEIN 27-JUL-12 4GBS TITLE CRYSTAL STRUCTURE OF A PUTATIVE LIPOPROTEIN (BF2707) FROM BACTEROIDES TITLE 2 FRAGILIS NCTC 9343 AT 2.75 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE LIPOPROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACTEROIDES FRAGILIS; SOURCE 3 ORGANISM_TAXID: 272559; SOURCE 4 STRAIN: NCTC 9343; SOURCE 5 GENE: BF2707, BF9343_2622; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS PF14064 FAMILY, TRANSPORT, STRUCTURAL GENOMICS, JOINT CENTER FOR KEYWDS 2 STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- KEYWDS 3 BIOLOGY, HEME-BINDING PROTEIN, LIPID BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 4 01-FEB-23 4GBS 1 REMARK SEQADV LINK REVDAT 3 24-JAN-18 4GBS 1 JRNL REVDAT 2 15-NOV-17 4GBS 1 REMARK REVDAT 1 10-OCT-12 4GBS 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF A PUTATIVE LIPOPROTEIN (BF2707) FROM JRNL TITL 2 BACTEROIDES FRAGILIS NCTC 9343 AT 2.75 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.48 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.10.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.48 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 21634 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 1106 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.48 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.60 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.67 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2792 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2326 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2641 REMARK 3 BIN R VALUE (WORKING SET) : 0.2300 REMARK 3 BIN FREE R VALUE : 0.2816 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.41 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 151 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2933 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 72 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 76.09 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 76.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.50590 REMARK 3 B22 (A**2) : -2.50590 REMARK 3 B33 (A**2) : 5.01170 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.467 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3027 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4143 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1322 ; 8.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 78 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 431 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3027 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 407 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3419 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.58 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.13 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|35 - 223 } REMARK 3 ORIGIN FOR THE GROUP (A): 73.4182 99.4287 26.4875 REMARK 3 T TENSOR REMARK 3 T11: -0.3116 T22: -0.0265 REMARK 3 T33: -0.1324 T12: -0.1059 REMARK 3 T13: -0.0358 T23: -0.0890 REMARK 3 L TENSOR REMARK 3 L11: 6.7555 L22: 4.1018 REMARK 3 L33: 3.6696 L12: 0.0926 REMARK 3 L13: 2.1841 L23: 1.1800 REMARK 3 S TENSOR REMARK 3 S11: 0.0772 S12: -0.4843 S13: 0.6149 REMARK 3 S21: 0.0732 S22: -0.3397 S23: -0.1551 REMARK 3 S31: 0.2220 S32: -0.4431 S33: 0.2625 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|38 - 223 } REMARK 3 ORIGIN FOR THE GROUP (A): 111.4080 94.3640 10.2489 REMARK 3 T TENSOR REMARK 3 T11: -0.1845 T22: -0.0805 REMARK 3 T33: -0.2406 T12: 0.0047 REMARK 3 T13: -0.1575 T23: -0.0466 REMARK 3 L TENSOR REMARK 3 L11: 4.4258 L22: 5.0144 REMARK 3 L33: 6.5774 L12: -2.4755 REMARK 3 L13: -3.5016 L23: 3.4944 REMARK 3 S TENSOR REMARK 3 S11: 0.2667 S12: 0.4238 S13: -0.2718 REMARK 3 S21: -0.6655 S22: -0.3092 S23: 0.3241 REMARK 3 S31: -0.1569 S32: -0.1330 S33: 0.0425 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. A MET-INHIBITION PROTOCOL WAS USED REMARK 3 FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. REMARK 3 THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 2. ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B REMARK 3 FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U REMARK 3 FACTORS. 3. THE MAD PHASES WERE USED AS RESTRAINTS DURING REMARK 3 REFINEMENT. 4. NCS RESTRAINTS WERE APPLIED USING BUSTER'S LSSR REMARK 3 RESTRAINT REPRESENTATION (-AUTONCS).5.THE PROTEIN WAS SUBJECTED REMARK 3 TO REDUCTIVE METHYLATION PRIOR TO CRYSTALLIZATION. LYSINE 101 REMARK 3 APPEARS TO HAVE BEEN PROTECTED FROM REDUCTIVE METHYLATION AND REMARK 3 WAS MODELED AS LYSINE. ALL OTHER LYSINES HAVE BEEN MODELED AS N- REMARK 3 DIMETHYL-LYSINE (MLY). 6. SULFATE MOLECULES(SO4) FROM THE REMARK 3 CRYSTALLIZATION HAVE BEEN MODELED INTO THE STRUCTURE. REMARK 4 REMARK 4 4GBS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000073986. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-MAY-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795,0.9184 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : RHODIUM-COATED VERTICAL AND REMARK 200 HORIZONTAL FOCUSING MIRRORS; REMARK 200 LIQUID-NITROGEN COOLED DOUBLE REMARK 200 CRYSTAL SI(111) MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE MARCH 15, 2012 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21701 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.480 REMARK 200 RESOLUTION RANGE LOW (A) : 46.676 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.48 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.57 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.17000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHARP, SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.40M AMMONIUM SULFATE, 0.1M BICINE PH REMARK 280 9.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+3/4 REMARK 290 8555 -Y,-X,-Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 131.72850 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 65.86425 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 197.59275 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 131.72850 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 197.59275 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 65.86425 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 ASN A 25 REMARK 465 GLY A 26 REMARK 465 ILE A 27 REMARK 465 LEU A 28 REMARK 465 SER A 29 REMARK 465 SER A 30 REMARK 465 LEU A 31 REMARK 465 TYR A 32 REMARK 465 ASP A 33 REMARK 465 GLU A 34 REMARK 465 MSE A 147 REMARK 465 GLU A 148 REMARK 465 ASP A 149 REMARK 465 ASN A 150 REMARK 465 GLY B 0 REMARK 465 ASN B 25 REMARK 465 GLY B 26 REMARK 465 ILE B 27 REMARK 465 LEU B 28 REMARK 465 SER B 29 REMARK 465 SER B 30 REMARK 465 LEU B 31 REMARK 465 TYR B 32 REMARK 465 ASP B 33 REMARK 465 GLU B 34 REMARK 465 PRO B 35 REMARK 465 GLU B 36 REMARK 465 THR B 37 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MLY A 39 CG CD CE NZ CH1 CH2 REMARK 470 MLY A 79 CG CD CE NZ CH1 CH2 REMARK 470 MLY A 119 NZ CH1 CH2 REMARK 470 SER A 144 OG REMARK 470 MSE A 146 CG SE CE REMARK 470 TYR A 152 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 MLY B 39 CG CD CE NZ CH1 CH2 REMARK 470 ASP B 40 CG OD1 OD2 REMARK 470 MLY B 119 CH1 CH2 REMARK 470 GLU B 148 CG CD OE1 OE2 REMARK 470 ASP B 149 CG OD1 OD2 REMARK 470 GLU B 174 CG CD OE1 OE2 REMARK 470 MSE B 175 CG SE CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 97 -120.51 53.20 REMARK 500 ASN A 103 76.86 -102.62 REMARK 500 ARG B 97 -119.33 52.64 REMARK 500 ASN B 103 76.45 -102.59 REMARK 500 MLY B 138 -50.26 -120.22 REMARK 500 MLY B 138 -50.73 -120.28 REMARK 500 ASP B 149 -108.65 -71.98 REMARK 500 ASN B 150 52.99 -95.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: JCSG-396942 RELATED DB: TARGETTRACK REMARK 999 REMARK 999 SEQUENCE REMARK 999 1. THE CONSTRUCT (RESIDUES 25-223) WAS EXPRESSED WITH AN N-TERMINAL REMARK 999 PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV REMARK 999 PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET REMARK 999 SEQUENCE. 2. THE PROTEIN WAS REDUCTIVELY METHYLATED PRIOR TO REMARK 999 CRYSTALLIZATION. DBREF 4GBS A 25 223 UNP Q5LBW5 Q5LBW5_BACFN 25 223 DBREF 4GBS B 25 223 UNP Q5LBW5 Q5LBW5_BACFN 25 223 SEQADV 4GBS GLY A 0 UNP Q5LBW5 EXPRESSION TAG SEQADV 4GBS GLY B 0 UNP Q5LBW5 EXPRESSION TAG SEQRES 1 A 200 GLY ASN GLY ILE LEU SER SER LEU TYR ASP GLU PRO GLU SEQRES 2 A 200 THR ALA MLY ASP PHE GLY PHE ILE THR ILE ASP HIS ALA SEQRES 3 A 200 ASN HIS SER GLY THR VAL ARG VAL ASP ALA THR GLN TYR SEQRES 4 A 200 THR MLY TRP ASN TYR ILE ASN LEU HIS THR LEU GLN ILE SEQRES 5 A 200 ASP SER ALA MLY VAL THR ALA GLU GLY ALA ASP ASP PRO SEQRES 6 A 200 ASP THR TRP ASP LEU ALA ILE HIS ARG TYR ASP VAL LYS SEQRES 7 A 200 THR ASN GLY GLY GLU VAL LEU GLU THR ASP TYR GLN SER SEQRES 8 A 200 LEU SER ALA LEU MLY ASN ALA GLY SER MSE PRO GLN GLY SEQRES 9 A 200 ILE PHE VAL ALA ASP GLU TRP THR THR ASN MLY ILE ALA SEQRES 10 A 200 VAL ASP VAL SER HIS MSE MSE GLU ASP ASN GLY TYR LEU SEQRES 11 A 200 ILE TYR ALA PRO SER ASP PHE ASN PRO GLU LEU SER MLY SEQRES 12 A 200 TRP LEU ASN VAL ASP THR SER GLU MSE PRO PRO ILE TYR SEQRES 13 A 200 THR PRO SER ASN MLY VAL TYR LEU LEU ARG MSE MLY ASP SEQRES 14 A 200 ASP THR MSE ALA ALA ILE ARG LEU VAL SER TYR MSE ASN SEQRES 15 A 200 ALA ALA GLY ILE MLY GLY TYR MSE THR PHE ASP TYR ILE SEQRES 16 A 200 TYR PRO TYR GLU PRO SEQRES 1 B 200 GLY ASN GLY ILE LEU SER SER LEU TYR ASP GLU PRO GLU SEQRES 2 B 200 THR ALA MLY ASP PHE GLY PHE ILE THR ILE ASP HIS ALA SEQRES 3 B 200 ASN HIS SER GLY THR VAL ARG VAL ASP ALA THR GLN TYR SEQRES 4 B 200 THR MLY TRP ASN TYR ILE ASN LEU HIS THR LEU GLN ILE SEQRES 5 B 200 ASP SER ALA MLY VAL THR ALA GLU GLY ALA ASP ASP PRO SEQRES 6 B 200 ASP THR TRP ASP LEU ALA ILE HIS ARG TYR ASP VAL LYS SEQRES 7 B 200 THR ASN GLY GLY GLU VAL LEU GLU THR ASP TYR GLN SER SEQRES 8 B 200 LEU SER ALA LEU MLY ASN ALA GLY SER MSE PRO GLN GLY SEQRES 9 B 200 ILE PHE VAL ALA ASP GLU TRP THR THR ASN MLY ILE ALA SEQRES 10 B 200 VAL ASP VAL SER HIS MSE MSE GLU ASP ASN GLY TYR LEU SEQRES 11 B 200 ILE TYR ALA PRO SER ASP PHE ASN PRO GLU LEU SER MLY SEQRES 12 B 200 TRP LEU ASN VAL ASP THR SER GLU MSE PRO PRO ILE TYR SEQRES 13 B 200 THR PRO SER ASN MLY VAL TYR LEU LEU ARG MSE MLY ASP SEQRES 14 B 200 ASP THR MSE ALA ALA ILE ARG LEU VAL SER TYR MSE ASN SEQRES 15 B 200 ALA ALA GLY ILE MLY GLY TYR MSE THR PHE ASP TYR ILE SEQRES 16 B 200 TYR PRO TYR GLU PRO MODRES 4GBS MLY A 39 LYS N-DIMETHYL-LYSINE MODRES 4GBS MLY A 64 LYS N-DIMETHYL-LYSINE MODRES 4GBS MLY A 79 LYS N-DIMETHYL-LYSINE MODRES 4GBS MLY A 119 LYS N-DIMETHYL-LYSINE MODRES 4GBS MSE A 124 MET SELENOMETHIONINE MODRES 4GBS MLY A 138 LYS N-DIMETHYL-LYSINE MODRES 4GBS MSE A 146 MET SELENOMETHIONINE MODRES 4GBS MLY A 166 LYS N-DIMETHYL-LYSINE MODRES 4GBS MSE A 175 MET SELENOMETHIONINE MODRES 4GBS MLY A 184 LYS N-DIMETHYL-LYSINE MODRES 4GBS MSE A 190 MET SELENOMETHIONINE MODRES 4GBS MLY A 191 LYS N-DIMETHYL-LYSINE MODRES 4GBS MSE A 195 MET SELENOMETHIONINE MODRES 4GBS MSE A 204 MET SELENOMETHIONINE MODRES 4GBS MLY A 210 LYS N-DIMETHYL-LYSINE MODRES 4GBS MSE A 213 MET SELENOMETHIONINE MODRES 4GBS MLY B 39 LYS N-DIMETHYL-LYSINE MODRES 4GBS MLY B 64 LYS N-DIMETHYL-LYSINE MODRES 4GBS MLY B 79 LYS N-DIMETHYL-LYSINE MODRES 4GBS MLY B 119 LYS N-DIMETHYL-LYSINE MODRES 4GBS MSE B 124 MET SELENOMETHIONINE MODRES 4GBS MLY B 138 LYS N-DIMETHYL-LYSINE MODRES 4GBS MSE B 146 MET SELENOMETHIONINE MODRES 4GBS MSE B 147 MET SELENOMETHIONINE MODRES 4GBS MLY B 166 LYS N-DIMETHYL-LYSINE MODRES 4GBS MSE B 175 MET SELENOMETHIONINE MODRES 4GBS MLY B 184 LYS N-DIMETHYL-LYSINE MODRES 4GBS MSE B 190 MET SELENOMETHIONINE MODRES 4GBS MLY B 191 LYS N-DIMETHYL-LYSINE MODRES 4GBS MSE B 195 MET SELENOMETHIONINE MODRES 4GBS MSE B 204 MET SELENOMETHIONINE MODRES 4GBS MLY B 210 LYS N-DIMETHYL-LYSINE MODRES 4GBS MSE B 213 MET SELENOMETHIONINE HET MLY A 39 5 HET MLY A 64 11 HET MLY A 79 5 HET MLY A 119 8 HET MSE A 124 8 HET MLY A 138 11 HET MSE A 146 5 HET MLY A 166 11 HET MSE A 175 8 HET MLY A 184 11 HET MSE A 190 8 HET MLY A 191 11 HET MSE A 195 8 HET MSE A 204 8 HET MLY A 210 11 HET MSE A 213 8 HET MLY B 39 5 HET MLY B 64 11 HET MLY B 79 11 HET MLY B 119 9 HET MSE B 124 8 HET MLY B 138 19 HET MSE B 146 8 HET MSE B 147 8 HET MLY B 166 11 HET MSE B 175 5 HET MLY B 184 11 HET MSE B 190 8 HET MLY B 191 11 HET MSE B 195 8 HET MSE B 204 8 HET MLY B 210 11 HET MSE B 213 8 HET SO4 A 301 5 HET SO4 B 301 5 HETNAM MLY N-DIMETHYL-LYSINE HETNAM MSE SELENOMETHIONINE HETNAM SO4 SULFATE ION FORMUL 1 MLY 18(C8 H18 N2 O2) FORMUL 1 MSE 15(C5 H11 N O2 SE) FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 HOH *72(H2 O) HELIX 1 1 THR A 37 PHE A 41 5 5 HELIX 2 2 SER A 114 GLY A 122 1 9 HELIX 3 3 GLU A 163 MLY A 166 5 4 HELIX 4 4 SER B 114 GLY B 122 1 9 HELIX 5 5 GLU B 163 MLY B 166 5 4 SHEET 1 A 7 GLY A 42 ASP A 47 0 SHEET 2 A 7 SER A 52 ASP A 58 -1 O ARG A 56 N GLY A 42 SHEET 3 A 7 MLY A 210 ILE A 218 -1 O PHE A 215 N VAL A 55 SHEET 4 A 7 MSE A 195 MSE A 204 -1 N ARG A 199 O ASP A 216 SHEET 5 A 7 TYR A 186 ARG A 189 -1 N TYR A 186 O ILE A 198 SHEET 6 A 7 GLU A 106 GLU A 109 -1 N GLU A 106 O ARG A 189 SHEET 7 A 7 VAL A 130 ALA A 131 -1 O VAL A 130 N VAL A 107 SHEET 1 B 5 GLY A 84 ALA A 85 0 SHEET 2 B 5 GLN A 74 THR A 81 -1 N THR A 81 O GLY A 84 SHEET 3 B 5 MLY A 64 ASN A 69 -1 N ASN A 69 O GLN A 74 SHEET 4 B 5 LEU A 93 HIS A 96 -1 O LEU A 93 N ILE A 68 SHEET 5 B 5 ASP A 99 THR A 102 -1 O ASP A 99 N HIS A 96 SHEET 1 C 2 GLU A 133 ASP A 142 0 SHEET 2 C 2 ILE A 154 PHE A 160 -1 O PHE A 160 N GLU A 133 SHEET 1 D 2 LEU A 168 ASP A 171 0 SHEET 2 D 2 ILE A 178 PRO A 181 -1 O THR A 180 N ASN A 169 SHEET 1 E 7 GLY B 42 ASP B 47 0 SHEET 2 E 7 SER B 52 ASP B 58 -1 O ARG B 56 N GLY B 42 SHEET 3 E 7 MLY B 210 ILE B 218 -1 O MSE B 213 N VAL B 57 SHEET 4 E 7 MSE B 195 MSE B 204 -1 N VAL B 201 O THR B 214 SHEET 5 E 7 TYR B 186 ARG B 189 -1 N TYR B 186 O ILE B 198 SHEET 6 E 7 GLU B 106 GLU B 109 -1 N GLU B 106 O ARG B 189 SHEET 7 E 7 VAL B 130 ALA B 131 -1 O VAL B 130 N VAL B 107 SHEET 1 F 5 GLY B 84 ALA B 85 0 SHEET 2 F 5 GLN B 74 THR B 81 -1 N THR B 81 O GLY B 84 SHEET 3 F 5 MLY B 64 ASN B 69 -1 N ASN B 69 O GLN B 74 SHEET 4 F 5 LEU B 93 HIS B 96 -1 O LEU B 93 N ILE B 68 SHEET 5 F 5 ASP B 99 THR B 102 -1 O ASP B 99 N HIS B 96 SHEET 1 G 2 GLU B 133 ASP B 142 0 SHEET 2 G 2 ILE B 154 PHE B 160 -1 O ILE B 154 N VAL B 141 SHEET 1 H 2 LEU B 168 ASP B 171 0 SHEET 2 H 2 ILE B 178 PRO B 181 -1 O THR B 180 N ASN B 169 LINK C ALA A 38 N MLY A 39 1555 1555 1.35 LINK C MLY A 39 N ASP A 40 1555 1555 1.35 LINK C THR A 63 N MLY A 64 1555 1555 1.32 LINK C MLY A 64 N TRP A 65 1555 1555 1.34 LINK C ALA A 78 N MLY A 79 1555 1555 1.34 LINK C MLY A 79 N VAL A 80 1555 1555 1.33 LINK C LEU A 118 N MLY A 119 1555 1555 1.35 LINK C MLY A 119 N ASN A 120 1555 1555 1.35 LINK C SER A 123 N MSE A 124 1555 1555 1.34 LINK C MSE A 124 N PRO A 125 1555 1555 1.36 LINK C ASN A 137 N MLY A 138 1555 1555 1.36 LINK C MLY A 138 N ILE A 139 1555 1555 1.34 LINK C HIS A 145 N MSE A 146 1555 1555 1.35 LINK C SER A 165 N MLY A 166 1555 1555 1.35 LINK C MLY A 166 N TRP A 167 1555 1555 1.37 LINK C GLU A 174 N MSE A 175 1555 1555 1.34 LINK C MSE A 175 N PRO A 176 1555 1555 1.36 LINK C ASN A 183 N MLY A 184 1555 1555 1.34 LINK C MLY A 184 N VAL A 185 1555 1555 1.34 LINK C ARG A 189 N MSE A 190 1555 1555 1.33 LINK C MSE A 190 N MLY A 191 1555 1555 1.35 LINK C MLY A 191 N ASP A 192 1555 1555 1.36 LINK C THR A 194 N MSE A 195 1555 1555 1.33 LINK C MSE A 195 N ALA A 196 1555 1555 1.33 LINK C TYR A 203 N MSE A 204 1555 1555 1.33 LINK C MSE A 204 N ASN A 205 1555 1555 1.34 LINK C ILE A 209 N MLY A 210 1555 1555 1.32 LINK C MLY A 210 N GLY A 211 1555 1555 1.33 LINK C TYR A 212 N MSE A 213 1555 1555 1.35 LINK C MSE A 213 N THR A 214 1555 1555 1.33 LINK C ALA B 38 N MLY B 39 1555 1555 1.36 LINK C MLY B 39 N ASP B 40 1555 1555 1.36 LINK C THR B 63 N MLY B 64 1555 1555 1.33 LINK C MLY B 64 N TRP B 65 1555 1555 1.35 LINK C ALA B 78 N MLY B 79 1555 1555 1.33 LINK C MLY B 79 N VAL B 80 1555 1555 1.32 LINK C LEU B 118 N MLY B 119 1555 1555 1.35 LINK C MLY B 119 N ASN B 120 1555 1555 1.35 LINK C SER B 123 N MSE B 124 1555 1555 1.33 LINK C MSE B 124 N PRO B 125 1555 1555 1.36 LINK C ASN B 137 N MLY B 138 1555 1555 1.35 LINK C MLY B 138 N ILE B 139 1555 1555 1.35 LINK C HIS B 145 N MSE B 146 1555 1555 1.33 LINK C MSE B 146 N MSE B 147 1555 1555 1.35 LINK C MSE B 147 N GLU B 148 1555 1555 1.36 LINK C SER B 165 N MLY B 166 1555 1555 1.34 LINK C MLY B 166 N TRP B 167 1555 1555 1.37 LINK C GLU B 174 N MSE B 175 1555 1555 1.35 LINK C MSE B 175 N PRO B 176 1555 1555 1.36 LINK C ASN B 183 N MLY B 184 1555 1555 1.35 LINK C MLY B 184 N VAL B 185 1555 1555 1.34 LINK C ARG B 189 N MSE B 190 1555 1555 1.33 LINK C MSE B 190 N MLY B 191 1555 1555 1.35 LINK C MLY B 191 N ASP B 192 1555 1555 1.36 LINK C THR B 194 N MSE B 195 1555 1555 1.33 LINK C MSE B 195 N ALA B 196 1555 1555 1.34 LINK C TYR B 203 N MSE B 204 1555 1555 1.36 LINK C MSE B 204 N ASN B 205 1555 1555 1.35 LINK C ILE B 209 N MLY B 210 1555 1555 1.33 LINK C MLY B 210 N GLY B 211 1555 1555 1.32 LINK C TYR B 212 N MSE B 213 1555 1555 1.34 LINK C MSE B 213 N THR B 214 1555 1555 1.34 CISPEP 1 MSE A 175 PRO A 176 0 -1.84 CISPEP 2 TYR A 219 PRO A 220 0 0.51 CISPEP 3 MSE B 175 PRO B 176 0 1.29 CISPEP 4 TYR B 219 PRO B 220 0 0.63 SITE 1 AC1 4 SER A 114 LEU A 115 SER A 116 HOH A 433 SITE 1 AC2 3 GLN B 61 MLY B 64 MLY B 79 CRYST1 66.009 66.009 263.457 90.00 90.00 90.00 P 41 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015149 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015149 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003796 0.00000